Luca Salernitano

New EU Regulation Extends Financial Penalties To Entities Beyond The Marketing Authorization Holder And Updates The Legal Framework For Medicinal Products For Human Use

Europe—New Regulation (EU) 2019/5 Extends Financial Penalties To Entities Beyond The Marketing Authorization Holder And Updates The Legal Framework For Medicinal Products For Human Use

Europe—General Court Confirms Obligation To Prove Significant Benefit Over All Authorized Medicinal Products, Including Those Authorized After The Submission Of The Marketing Authorization Application For The Future (Orphan) Product

Europe—Brexit Alert on Cosmetic Products

European Commission's Update Of Guideline On Duplicate Marketing Authorizations To Cover Biosimilars